Skip to main content

HSBC HOLDINGS PLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 873630 LONDON, X0

Position in NBIX

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$24,269,403
+$14,583,553 QoQ
Shares Held
184,222
+169.8% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $402,454,379 across 27 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (6.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
184,222 $24,269,403

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $24,269,403 184,222
2025-12-31 $9,685,850 68,292
2025-09-30 $25,781,767 183,657
2025-06-30 $23,785,195 189,237
2025-03-31 $26,879,668 243,035
2024-12-31 $28,986,320 212,354
2024-09-30 $25,723,784 223,258
2024-06-30 $15,566,755 113,073
2024-03-31 $19,290,316 139,866
2023-12-31 $13,697,241 103,956
2023-09-30 $8,772,862 77,981
2023-06-30 $7,258,174 76,969
2023-03-31 $11,631,693 114,915
2022-12-31 $9,352,030 78,299
2022-09-30 $7,223,126 68,008
2022-06-30 $5,719,539 58,674
2022-03-31 $5,452,124 58,156
2021-12-31 $4,545,946 53,375
2021-09-30 $4,258,401 44,400
2021-06-30 $2,976,336 30,583
2021-03-31 $994,476 10,226
2020-12-31 $1,573,472 16,416
2020-09-30 $1,445,956 15,037
2020-06-30 $2,266,394 18,577
2020-03-31 $571,402 6,602